FDA-Drug2017-06-28Class II
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Lucid Pharma LLC
Hazard
Failed Tablet/Capsules Specifications: pharmacists complaints for bottles containing melted capsules.
Sold states
Nationwide in the USA
Affected count
a) 44168 bottles; b) 24960 bottles
Manufactured in
2 Tower Center Blvd, Suite 1101B, East Brunswick, NJ, United States
Products
Venlafaxine Hydrochloride Extended-Release Capsules USP, 75 mg, packaged in a) 30-count bottles (NDC 52343-132-30) and b) 90-count bottles (NDC 52343-132-90), Rx only, Distributed by: Lucid Pharma LLC, 2 Tower Center Blvd, Suite-1101-B, East Brunswick, NJ 08816 USA.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0921-2017Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief